These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7107370)

  • 21. Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range.
    Grdina DJ; Thames HD; Milas L
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):379-83. PubMed ID: 6706731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
    Siemann DW; Hill SA
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined treatment of radiation and local injections of misonidazole.
    Hong SS; Abe Y; Kaneta K; Matsuzawa T
    Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2369-73. PubMed ID: 6511531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
    Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
    Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular absorption and toxicity of a radiosensitizer and its effect on hypoxic cells.
    Rootman J; Josephy PD; Adomat H; Palcic B
    Arch Ophthalmol; 1982 Mar; 100(3):468-71. PubMed ID: 7199901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW; Maddison K; Wolf K
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I study of the hypoxic cell radiosensitizer Ro-03-8799.
    Roberts JT; Bleehen NM; Workman P; Walton MI
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1755-8. PubMed ID: 6480458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of misonidazole as a hypoxic radiosensitizer at low dose.
    Palcic B; Faddegon B; Skarsgard LD
    Radiat Res; 1984 Nov; 100(2):340-7. PubMed ID: 6494445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ; de Ronde J; Hinchliffe M
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
    Brown JM; Yu NY; Workman P
    Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing of hypoxic cell radiosensitizers in vivo.
    Denekamp J
    Cancer Clin Trials; 1980; 3(2):139-48. PubMed ID: 7428137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
    Tada T; Nakajima T; Onoyama Y; Murayama C; Mori T; Nagasawa H; Hori H; Inayama S
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):601-5. PubMed ID: 8005823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of misonidazole during continuous low dose rate irradiation.
    Fu KK; Hurst S; Begg AC; Brown JM
    Cancer Clin Trials; 1980; 3(3):257-65. PubMed ID: 7438323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of misonidazole in situ on the radiation response of selected tumor subpopoulations.
    Grdina DJ; Sigdestad CP; Jovonovich JA
    Cancer Clin Trials; 1980; 3(2):149-54. PubMed ID: 7428138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desmethylmisonidazole (Ro 05-9963): clinical pharmacokinetics after multiple oral administration.
    Stratford MR; Minchinton AI; Dische S; Saunders MI; Anderson P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):377-9. PubMed ID: 7107355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure.
    Schwade JG; Kinsella TJ; Kelly B; Rowland J; Johnston M; Glatstein E
    Cancer Invest; 1984; 2(2):91-5. PubMed ID: 6733563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiosensitization in vivo: a study with an homologous series of 2-nitroimidazoles.
    Chaplin DJ; Sheldon PW; Stratford IJ; Ahmed I; Adams GE
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Oct; 44(4):387-98. PubMed ID: 6605324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
    Hinchliffe M; McNally NJ
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM; Yu NY; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of hyperthermia on cytotoxicity of the radiosensitizer Ro-07-0582 in a solid mouse tumour.
    George KC; Hirst DG; McNally NJ
    Br J Cancer; 1977 Mar; 35(3):372-5. PubMed ID: 851513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.